RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 109 filers reported holding RUBIUS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.41 and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,375 | +237.5% | 19,286 | +501.4% | 0.00% | – |
| Q3 2022 | $1,000 | -99.4% | 3,207 | -98.5% | 0.00% | – |
| Q2 2022 | $180,000 | -75.2% | 211,551 | +60.5% | 0.00% | – |
| Q1 2022 | $726,000 | +19.6% | 131,797 | +110.1% | 0.00% | – |
| Q4 2021 | $607,000 | -18.1% | 62,724 | +51.3% | 0.00% | – |
| Q3 2021 | $741,000 | +93.0% | 41,456 | +162.9% | 0.00% | – |
| Q2 2021 | $384,000 | -16.5% | 15,771 | -9.1% | 0.00% | – |
| Q1 2021 | $460,000 | +133.5% | 17,358 | -32.9% | 0.00% | – |
| Q4 2020 | $197,000 | +75.9% | 25,871 | +15.5% | 0.00% | – |
| Q3 2020 | $112,000 | +5.7% | 22,403 | +26.4% | 0.00% | – |
| Q2 2020 | $106,000 | +63.1% | 17,725 | +22.6% | 0.00% | – |
| Q1 2020 | $65,000 | -60.4% | 14,453 | -16.6% | 0.00% | – |
| Q4 2019 | $164,000 | -21.5% | 17,324 | -35.1% | 0.00% | – |
| Q3 2019 | $209,000 | -40.5% | 26,676 | +19.4% | 0.00% | – |
| Q2 2019 | $351,000 | +174.2% | 22,343 | +214.6% | 0.00% | – |
| Q1 2019 | $128,000 | -28.1% | 7,103 | -35.7% | 0.00% | – |
| Q4 2018 | $178,000 | +368.4% | 11,048 | +601.5% | 0.00% | – |
| Q3 2018 | $38,000 | – | 1,575 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |